Incidence of cancer set to rise: Lancet study

Between 2018 and 2040, the number of patients requiring first-course chemotherapy annually will increase from 9.8 million to 15 million.

A study published in The Lancet, Oncology estimates that a steady growth curve of patients (eligible for chemotherapy) will be seen in low and middle income countries going from 63% in 2018 to 67% in 2040.

The most common indications for chemotherapy worldwide in 2040 will be lung cancer 16.4%, breast cancer 12.7% and colorectal cancer 11.1%. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *